Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al Aly

Showing results (31-40 of 140) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|May 10, 2023
Molnupiravir and risk of post-acute sequelae of covid-19: cohort studyYan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Medicine|November 10, 2022
Acute and postacute sequelae associated with SARS-CoV-2 reinfectionBenjamin Bowe, Yan Xie, Ziyad Al-Aly
The New England Journal of Medicine|October 8, 2025
Association of 2024-2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. VeteransMiao Cai, Yan Xie, Ziyad Al-Aly
Communications Medicine|September 11, 2024
Adverse cardiovascular and kidney outcomes in people with SARS-CoV-2 treated with SGLT2 inhibitorsTaeyoung Choi, Yan Xie, Ziyad Al-Aly
Annals of Internal Medicine|June 29, 2026
Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial EmulationYan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Communications|November 13, 2021
Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health statusYan Xie, Benjamin Bowe, Ziyad Al-Aly
Nature Communications|March 7, 2023
Long-term gastrointestinal outcomes of COVID-19Evan Xu, Yan Xie, Ziyad Al-Aly
Nature Medicine|January 20, 2025
Mapping the effectiveness and risks of GLP-1 receptor agonistsYan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Medicine|August 21, 2023
Postacute sequelae of COVID-19 at 2 yearsBenjamin Bowe, Yan Xie, Ziyad Al-Aly
Current Opinion in Nephrology and Hypertension|February 13, 2018
The association of proton pump inhibitors and chronic kidney disease: cause or confounding?Tingting Li, Yan Xie, Ziyad Al-Aly
Pageof 14

Showing results (31-40 of 140) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|May 10, 2023
Molnupiravir and risk of post-acute sequelae of covid-19: cohort studyYan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Medicine|November 10, 2022
Acute and postacute sequelae associated with SARS-CoV-2 reinfectionBenjamin Bowe, Yan Xie, Ziyad Al-Aly
The New England Journal of Medicine|October 8, 2025
Association of 2024-2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. VeteransMiao Cai, Yan Xie, Ziyad Al-Aly
Communications Medicine|September 11, 2024
Adverse cardiovascular and kidney outcomes in people with SARS-CoV-2 treated with SGLT2 inhibitorsTaeyoung Choi, Yan Xie, Ziyad Al-Aly
Annals of Internal Medicine|June 29, 2026
Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial EmulationYan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Communications|November 13, 2021
Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health statusYan Xie, Benjamin Bowe, Ziyad Al-Aly
Nature Communications|March 7, 2023
Long-term gastrointestinal outcomes of COVID-19Evan Xu, Yan Xie, Ziyad Al-Aly
Nature Medicine|January 20, 2025
Mapping the effectiveness and risks of GLP-1 receptor agonistsYan Xie, Taeyoung Choi, Ziyad Al-Aly
Nature Medicine|August 21, 2023
Postacute sequelae of COVID-19 at 2 yearsBenjamin Bowe, Yan Xie, Ziyad Al-Aly
Current Opinion in Nephrology and Hypertension|February 13, 2018
The association of proton pump inhibitors and chronic kidney disease: cause or confounding?Tingting Li, Yan Xie, Ziyad Al-Aly
Pageof 14